-
Simulation of the Impact on LDLC Targets and Treatment Cost in High and Very High Cardiovascular Risk Patients of Cost-Based Sequencing of Lipid-Lowering Therapy
Sep 9, 2025, 16:22 PM -
Comparing Individualized Treatment Effect Inference Methods Through a Simulation Study
Sep 9, 2025, 16:22 PM -
Comparing Risk of Bias Assessment Requirements Between the EU JCA and European HTA Agencies
Sep 9, 2025, 16:22 PM -
What About a Latent Cure Model? Assessing Cure Models’ Performance in Pediatric Acute Lymphoblastic Leukemia Treated With Tisagenlecleucel
Sep 9, 2025, 16:22 PM -
A Review of Health Economic Modeling Challenges for Opioid Use Disorder Treatment in Prison Settings
Sep 9, 2025, 16:22 PM -
Regulatory Timelines for CMA Medicines In Italy: A Comparative Analysis of Pricing and Reimbursement Procedures
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Minocycline Intravenous for the Treatment of Serious Infections Due to Multidrug-Resistant Acinetobacter baumannii in Jordan
Sep 9, 2025, 16:22 PM -
Eliciting Patients' and Clinicians' Preferences on Adjuvant Treatment for HR+/HER2- Early Breast Cancer: Design of a Probabilistic Threshold Technique in Italy
Sep 9, 2025, 16:22 PM -
Use of Innovative Methods in Long-Term Follow-up Observational Studies: An AI-Enabled Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Real-World Hospital Stays Description and Cost Analysis of Immune Checkpoint Inhibitors (ICIs) Using National PMSI Data in France
Sep 9, 2025, 16:22 PM -
Nephrotoxicity of Antisense Oligonucleotide Therapies in Duchenne Muscular Dystrophy: A Warning or a Challenge?
Sep 9, 2025, 16:22 PM -
Comorbidities As a Risk Predictor of Kidney Disease Progression Among Patients Diagnosed With Chronic Kidney Disease
Sep 9, 2025, 16:22 PM -
What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?
Sep 9, 2025, 16:22 PM -
Budget and Time Impact Analysis of Introducing Subcutaneous Pembrolizumab to Patients From Institution HCP and Patient Perspectives in the United States (US)
Sep 9, 2025, 16:22 PM -
The Role of Technological Innovation and Policy in the Evolution of Care Models in Italy
Sep 9, 2025, 16:22 PM -
BHM and BHM-Based Extrapolations in an HTA Framework
Sep 9, 2025, 16:22 PM -
Let LAMBA Do the Work: Can We Reduce Reliance on VBA in Health Economic Models?
Sep 9, 2025, 16:22 PM -
Estimand Framework in the Setting of Observational Studies: Current Landscape and Future Directions
Sep 9, 2025, 16:22 PM -
A Cost-Utility Analysis of Sparsentan for the Treatment of Immunoglobulin A Nephropathy in the UK
Sep 9, 2025, 16:22 PM -
Healthcare Pathway of a Large Cohort of Patients With Chronic Obstructive Pulmonary Disease During the Last Year of Life
Sep 9, 2025, 16:22 PM
